Preoperative Endovascular Embolization of Orbital Solitary Fibrous Tumor With 500-700 Micron Tris-Acryl Gelatin Microspheres

Creative Commons License

Yazıcı B., HAKYEMEZ B., Muz Ö. E., YAZICI Z., YALÇINKAYA Ü.

Turkish Journal of Ophthalmology, cilt.52, sa.5, ss.356-359, 2022 (ESCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52 Sayı: 5
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4274/tjo.galenos.2022.79438
  • Dergi Adı: Turkish Journal of Ophthalmology
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.356-359
  • Anahtar Kelimeler: Orbit, solitary fibrous tumor, surgical treatment, tumor embolization, tris-acryl gelatin microsphere, HEAD
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

© 2022 by Turkish Ophthalmological Association.The reported experience with preoperative embolization of solid orbital tumors is scarce. Herein, we present a case of a large and hypervascular orbital solitary fibrous tumor (SFT) in which 500-700 µm tris-acryl gelatin microspheres (TAGM) were used for preoperative embolization. A 41-year-old man presented with severe proptosis, palpable mass, restrictive myopathy, exposure keratopathy, and compressive optic neuropathy in the right orbit. Magnetic resonance imaging showed a 65x35x35 mm, diffusely contrast-enhanced tumor in the superior orbit, extending to the apex, and multiple intratumoral vascular flow voids. A diagnosis of SFT was made by incisional biopsy. Endovascular tumor embolization was performed with 500-700 µm TAGM. Two days later, the tumor was entirely removed with minimal bleeding. No embolization-or surgery-related complications and tumor recurrence or metastasis developed during the 42-month postoperative follow-up.